a1chieve , a multinational , 24-week , non - interventional study , assessed the safety and effectiveness of insulin analogues in people with t2 dm ( n = 66,726 ) in routine clinical care .
overall , body weight reduced in insulin nave group whereas no change in body weight was observed for insulin users .
though the findings are limited by number of patients , still the trend indicates that insulin analogues can be considered effective and possess a safe profile for treating type 2 diabetes in rajasthan , india .
major hypoglycaemic events decreased from 0.5 events / patient - year to 0.0 events / patient - year in insulin nave group while no change from baseline ( 1.3 events / patients - year ) was observed for insulin user group .
other groups were insulin detemir ( n = 28 ) , insulin aspart ( n = 24 ) , basal insulin plus insulin aspart ( n = 13 ) and other insulin combinations ( n = 3 ) . overall demographic data after 24 weeks of treatment , overall hypoglycaemic events reduced from 2.1 events / patient - year to 0.0 events / patient - year in insulin nave group and from 6.8 events / patient - year to 0.0 events / patient - year in insulin users group .